Delivery Order SPE2DB24D1205-SPE2DB25FCZNY
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of EUFLEXXA 1% 20 mg/2 ml syringes in 2 ml quantities. This is a firm fixed price delivery order with a ceiling value of $2,575.50 and an ultimate completion date of July 30, 2025. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. EUFLEXXA is a viscosupplementation...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML. The potential value of this delivery order is $3,485.16, with a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not designated as a set-aside contract. This delivery order is part of a larger indefinite delivery contract...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a potential value of $3,231.78. The contract has a completion date of February 9, 2024 and was awarded on February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not designated as a set-aside. The contract is...
- The Defense Logistics Agency awarded a $7,468.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20mg/2ml syringes of EUFLEXXA. As the prime contractor, Amerisourcebergen will deliver the product to a location in Conshohocken, Pennsylvania within the period of performance from August 22nd to August 23rd, 2023. The Defense Logistics Agency routinely procures medical supplies and pharmaceuticals to support Department of Defense operations worldwide. This delivery order...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML. The contract has a potential value of $8,961.84 and a completion date of March 7, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,365.78 firm fixed-price delivery order is for EUFLEXXA 20MG/2ML 3S medical supplies. The contract has an ultimate completion date of April 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded a delivery order valued at $746.85 to Amerisourcebergen Drug Corp under an indefinite-delivery/indefinite-quantity contract vehicle. The delivery order is for the provision of 20 mg/2 ml syringes of EUFLEXXA to support the Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period concluding on August 30, 2023. The contract utilizes a firm fixed price structure and does not include...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,891.70, is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The delivery order has an ultimate completion date of February 23, 2023. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp is the prime contractor, and there is no...
- The Defense Logistics Agency awarded a $5,228 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562102383 EUFLEXXA 20 MG/2 ML SYRINGE 2ML. The contract has a period of performance from September 8-11, 2023 for place of performance in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No major subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $20,422 delivery order to Amerisourcebergen Drug Corporation for EUFLEXXA 20 MG/2 ML SYRINGES. As the prime contractor, Amerisourcebergen will deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by July 28, 2023 under a firm fixed price contract. The parent company, Amerisourcebergen Corporation, will perform the order through its Corporate Office Division. No set aside designation or subcontractors were indicated....
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZNYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 mg/2 mL syringes with a ceiling value of $6,754.59 on August 14, 2025. This is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and no set-aside designation was used. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of medical product deliveries through open competition with the Defense Logistics Agency and Medical Supply Chain, supplying a comprehensive range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for EUFLEXXA syringes represents a routine transaction within AmerisourceBergen's broader federal contracting relationship, demonstrating the company's ongoing role in supporting Department of Defense medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 8/14/25 |